SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-16-130179
Filing Date
2016-06-29
Accepted
2016-06-29 18:52:50
Documents
2
Period of Report
2016-06-29

Document Format Files

Seq Description Document Type Size
1 3 a3.html 3  
1 3 a3.xml 3 2816
2 EX-24 ex-24.htm EX-24 10028
  Complete submission text file 0001104659-16-130179.txt   14311
Mailing Address MILLENNIUM PHARMACEUTICALS, INC. 40 LANDSDOWNE STREET CAMBRIDGE MA 02139
Business Address
Fanucci Marsha (Reporting) CIK: 0001298814 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37813 | Film No.: 161740019

Mailing Address 480 ARSENAL STREET SUITE 130 WATERTOWN MA 02472
Business Address 480 ARSENAL STREET SUITE 130 WATERTOWN MA 02472 617-744-1340
Syros Pharmaceuticals, Inc. (Issuer) CIK: 0001556263 (see all company filings)

IRS No.: 453772460 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations